| RSS
Business center
Office
Post trade leads
Post
Rank promotion
Ranking
 
You are at: Home » News » International »

FDA announces expansion of generic impurity investigation

Increase font size  Decrease font size Date:2019-09-03   Views:41

The US Food and Drug Administration (FDA) has announced that it will be expanding its investigation into impurities in US generic drugs beyond angiotensin II receptor blockers (ARBs), medicines for high blood pressure.

 
 
[ Search ]  [ ]  [ Email ]  [ Print ]  [ Close ]  [ Top ]

 
Total:0comment(s) [View All]  Related comment

 
Recomment
Popular
 
 
Home | About | Service | copyright | agreement | contact | about | SiteMap | Links | GuestBook | Ads service | 京ICP 68975478-1
Tel:+86-10-68645975           Fax:+86-10-68645973
E-mail:yaoshang68@163.com     QQ:1483838028